These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 20033767
1. Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis. Yu KD, Chen AX, Yang C, Qiu LX, Fan L, Xu WH, Shao ZM. Breast Cancer Res Treat; 2010 Jul; 122(1):251-7. PubMed ID: 20033767 [Abstract] [Full Text] [Related]
2. Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects. Yu KD, Di GH, Fan L, Chen AX, Yang C, Shao ZM. Breast Cancer Res Treat; 2010 Jul; 122(2):483-8. PubMed ID: 20043205 [Abstract] [Full Text] [Related]
3. XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects. Yu KD, Chen AX, Qiu LX, Fan L, Yang C, Shao ZM. Breast Cancer Res Treat; 2010 Aug; 123(1):219-25. PubMed ID: 20127279 [Abstract] [Full Text] [Related]
4. The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk. Yu KD, Chen AX, Yang C, Fan L, Huang AJ, Shao ZM. Breast Cancer Res Treat; 2012 Jan; 131(1):27-31. PubMed ID: 20737205 [Abstract] [Full Text] [Related]
5. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis. Yu KD, Chen AX, Shao ZM. Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999 [Abstract] [Full Text] [Related]
6. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis. Qiu LX, Mao C, Yao L, Yu KD, Zhan P, Chen B, Liu HG, Yuan H, Zhang J, Xue K, Hu XC. Breast Cancer Res Treat; 2010 Jul; 122(2):489-93. PubMed ID: 20049524 [Abstract] [Full Text] [Related]
7. Association between mitogen-activated protein kinase kinase kinase 1 rs889312 polymorphism and breast cancer risk: evidence from 59,977 subjects. Lu PH, Yang J, Li C, Wei MX, Shen W, Shi LP, Jiang ZY, Zhou N, Tao GQ. Breast Cancer Res Treat; 2011 Apr; 126(3):663-70. PubMed ID: 20809358 [Abstract] [Full Text] [Related]
8. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects. Qiu LX, Yao L, Xue K, Zhang J, Mao C, Chen B, Zhan P, Yuan H, Hu XC. Breast Cancer Res Treat; 2010 Sep; 123(2):487-90. PubMed ID: 20135345 [Abstract] [Full Text] [Related]
9. Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies. Li Q, Liu L, Liu Y, Zhou H, Yang Z, Yuan K, Min W. Med Oncol; 2015 Jan; 32(1):397. PubMed ID: 25433948 [Abstract] [Full Text] [Related]
10. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls. Gu D, Zhuang L, Huang H, Cao P, Wang D, Tang J, Chen J. Breast Cancer Res Treat; 2010 Oct; 123(3):857-61. PubMed ID: 20157775 [Abstract] [Full Text] [Related]
11. TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects. Qiu LX, Yao L, Mao C, Chen B, Zhan P, Xue K, Zhang J, Yuan H, Hu XC. Breast Cancer Res Treat; 2010 Sep; 123(2):563-7. PubMed ID: 20143152 [Abstract] [Full Text] [Related]
12. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects. Yao L, Yu X, Yu L. Breast Cancer Res Treat; 2010 Jul; 122(2):503-7. PubMed ID: 20052535 [Abstract] [Full Text] [Related]
13. Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects. Qiu LX, Yao L, Mao C, Chen B, Zhan P, Yuan H, Xue K, Zhang J, Hu XC. Breast Cancer Res Treat; 2010 Sep; 123(2):543-7. PubMed ID: 20143154 [Abstract] [Full Text] [Related]
14. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects. Qiu LX, Yao L, Mao C, Yu KD, Zhan P, Chen B, Yuan H, Zhang J, Xue K, Hu XC. Breast Cancer Res Treat; 2010 Jul; 122(2):521-5. PubMed ID: 20054636 [Abstract] [Full Text] [Related]
15. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects. Qiu LX, Yao L, Zhang J, Zhu XD, Zhao XM, Xue K, Mao C, Chen B, Zhan P, Yuan H, Hu XC. Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500 [Abstract] [Full Text] [Related]
16. IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls. Qiu LX, Yao L, Yuan H, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC. Breast Cancer Res Treat; 2010 Aug; 122(3):867-71. PubMed ID: 20084546 [Abstract] [Full Text] [Related]
17. The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis. Yao L, Fang F, Zhong Y, Yu L. Breast Cancer Res Treat; 2010 Nov; 124(1):223-7. PubMed ID: 20204503 [Abstract] [Full Text] [Related]
18. FAS promoter polymorphisms and cancer risk: a meta-analysis based on 34 case-control studies. Zhang Z, Xue H, Gong W, Wang M, Yuan L, Han S, Zhang Z. Carcinogenesis; 2009 Mar; 30(3):487-93. PubMed ID: 19168581 [Abstract] [Full Text] [Related]
19. The association between IGF1 CA repeat polymorphisms and breast cancer risk: a meta-analysis. Huang Q, Wang C, Qiu LJ, Shao F, Yu JH. Breast Cancer Res Treat; 2011 Aug; 129(1):191-4. PubMed ID: 21390492 [Abstract] [Full Text] [Related]
20. The association between HSD17B1 Ser312Gly polymorphism and breast cancer risk: a meta-analysis including 31,053 subjects. Yao L, Cao LH, Qiu LX, Yu L. Breast Cancer Res Treat; 2010 Sep; 123(2):577-80. PubMed ID: 20151320 [Abstract] [Full Text] [Related] Page: [Next] [New Search]